News

 

Alternative Method developed by Accelera – Metodo alternativo sviluppato da Accelera

Alternative Method developed by Accelera – Metodo alternativo sviluppato da Accelera

On September 21st were presented at the EU Commission Joint Research Center in Ispra the results of the method “Inhibition of thyroid hormones glucuronidation using liquid chromatography/mass spectrometry” developed by Accelera within the frame of the EU-NETVAL project, aimed at implementing new alternative (non-animal) methods to assess the potential disrupting effect of chemicals on the thyroid.

(Click the title for the complete article)

Accelera Srl Announces Nomination of Luca Leone as CEO of Accelera, a Leading Contract Research Organization

Accelera Srl Announces Nomination of Luca Leone as CEO of Accelera, a Leading Contract Research Organization

Nerviano, Italy_June_19_Accelera Srl (Accelera), a global leader in contract research and development services and a member of the NMS Group, is pleased to announce the nomination of Luca Leone as the new Chief Executive Officer (CEO) of the organization, effective immediately. The appointment of Luca comes at an exciting time for Accelera, as it continues to expand its services and drive innovation in the contract research organization (CRO) industry.

(Click the title for the complete article)

Dr. Claudio Bernardi has been appointed as a member of the Rentic National Commission

Dr. Claudio Bernardi has been appointed as a member of the Rentic National Commission

We are pleased to announce that Dr. Claudio Bernardi, Chief Operating Officer of Accelera Srl, has been appointed as a member of the Rentic National Commission, the organization evaluating the professional skills of the Italian Toxicologists. The Commission comprises a total of five Members, of which four belong to the academic world, and only one representative of private organisations.

Based on the mutual recognition amongst the European Toxicological Societies, the Rentic (Italian Register of Certified Toxicologists) recognition gives de-facto right to the approved toxicologists to be qualified as European Registered Toxicologist (ERT).
(Click the title for the complete article)

NMS Group certified as “Workplace that promotes health initiatives” again in 2022

NMS Group certified as “Workplace that promotes health initiatives” again in 2022

NMS group has joined the WHP program since 2017. The Workplace Health Promotion (WHP) is the combined efforts of employers, employees and society to improve the health and well-being of people at work. The promotion of a comfortable and healthy workplace has been one of the goals of NMS group since 2017.
(Click the title for the complete article)

Accelera sponsor del 21° congresso nazionale SITOX – Bologna (20-22 Febbraio 2023)

Accelera sponsor del 21° congresso nazionale SITOX – Bologna (20-22 Febbraio 2023)

Accelera è Sponsor del 21° congresso nazionale SITOX che si svolgerà a Bologna il giorno 21 febbraio (dalle 11.00 alle 12.00), presenterà il poster “Valutazione preclinica della tossicità a carico del SNC nel soggetto pediatrico: tecniche istologiche in neonati di ratto”.

nella sessione P3 Farmaci
Numero del poster: P3/1

(Click the title for the complete article)

NMS Group S.p.A. names Sidney Shin-Yi Dung as Chief Operating Officer to drive growth

NMS Group S.p.A. names Sidney Shin-Yi Dung as Chief Operating Officer to drive growth

NMS Group S.p.A. (NMS Group), the largest oncological R&D company in Italy, announces the appointment of Ms. Sidney Dung as Chief Operating Officer with immediate effect. Ms. Dung, currently a member of the Company’s Executive Leadership Team and Chief of Staff, will take primary responsibility for accelerating groupwise operational performance, continuing the transformation of the business model of each subsidiary and implementing the strategic vision and values of the company, in collaboration with leaders across the firm in her new role as COO.
(Click the title for the complete article)

Accelera Srl Announces Change in Board Composition Effective Today

Accelera Srl, leading CRO and a member of the NMS Group today announced the change in its Board Composition, following the resignation of its board member Enrico Pesenti, effective today. Hugues Dolgos, Pharm.D., CEO of NMS Group, is appointed as Sole Director of Accelera Srl.   
(Click the title for the complete article)

 

Welcome and Check out our new motion picture!

WATCH OUR VIDEO